Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2013-10-29 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return for a listed issuer, Uni-Bio Science Group Limited, reporting changes in issued share capital and share buybacks. It includes detailed tables on share issues and repurchases, referencing specific listing rules from the Hong Kong Stock Exchange. The content focuses on share capital changes and repurchase activities, with no financial statements or earnings data. This matches the definition of a Transaction in Own Shares (POS) filing, which reports company buybacks or share issuances. The document length is over 6,000 characters and contains substantive data, not just an announcement or certification. Therefore, the correct classification is POS with high confidence.
2013-10-29 English
ADJUSTMENT TO THE EXISTING SHARE OPTIONS
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding adjustments to existing share options due to completion of an Open Offer and Bonus Issue. It references the Share Option Scheme and adjustments to exercise price and number of shares under the scheme. The document is short (2972 characters) and is an announcement of changes related to share options, not a full financial report or detailed data. It does not contain financial statements or comprehensive financial analysis. This fits the category of Share Issue/Capital Change (SHA), as it relates to changes in share capital structure and share options adjustments.
2013-10-28 English
UNUSUAL SHARE PRICE AND TRADING VOLUME MOVEMENTS
Regulatory Filings Classification · 95% confidence The document is an announcement made at the request of the Stock Exchange of Hong Kong Limited regarding unusual share price and trading volume movements. It states that the Board is not aware of any price-sensitive information or negotiations related to acquisitions or realizations. The document is short (2013 characters) and serves as a regulatory disclosure to inform the market about unusual trading activity without providing financial data or detailed reports. It does not contain financial statements, management discussion, or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2013-10-28 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 95% confidence The document is a disclosure return related to changes in issued share capital and share buybacks for a listed issuer, Uni-Bio Science Group Limited. It includes detailed information on share issues, share repurchases, and compliance with listing rules. The content focuses on capital changes and repurchase activities rather than financial results, management commentary, or regulatory certifications. The document length is 6378 characters, which is sufficient to contain substantive data. This matches the description of a Share Issue/Capital Change filing, which covers announcements regarding new share issues, stock splits, or other capital changes. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2013-10-04 English
RESULTS OF THE OPEN OFFER WITH THE BONUS ISSUE
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the results of an Open Offer with a Bonus Issue by Uni-Bio Science Group Limited. It details the subscription results, underwriting agreement status, allotment of shares and warrants, shareholding structure before and after the offer, and related procedural information such as despatch of share certificates and commencement of trading. The document does not contain financial statements or detailed financial analysis but rather provides an update on a capital raising event and share issuance. It is not a full financial report, earnings release, or management discussion. It is also not a proxy statement, AGM material, or legal proceeding. The content fits the category of Capital/Financing Update as it relates to fundraising activities and changes in capital structure. The document length is substantial and contains detailed information about the offer results and share allotment, consistent with a capital/financing update announcement rather than a brief notice or regulatory filing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2013-10-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2013
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30 September 2013, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content focuses on changes in share capital and securities movements rather than financial performance, management commentary, or regulatory certifications. It is a regulatory filing reporting monthly share capital movements, typical for compliance with exchange requirements. It is not an annual or interim report, earnings release, or management discussion. The document is substantive and detailed, not a brief announcement or certification. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about share capital movements that does not fit more specific categories like Share Issue/Capital Change (SHA) because it covers a broad range of share capital movements and is a monthly return report to the exchange.
2013-10-02 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.